On Monday, the CMS outlined potential use of the funds — two-year grants ranging between $225,000 and $290,000 each — and emphasized market and economic studies for leveraging the Trump administration’s guidance and regulations to expand their individual market options. The agency also suggested states could use the money to analyze whether exchange enrollees get adequate access to mental health and addiction treatment, particularly opioid addiction treatment.
The CMS did not immediately respond to a request for clarification on where states can directly apply the money.
CMS Administrator Seema Verma in a statement stressed that states can use the money to tune the markets in their own way.
“These grants make yet another down payment on our work to enhance states’ ability to stabilize and improve their respective health insurance markets,” Verma said.
In October 2016, the Obama administration’s CMS applied unspent money on enforcement of federal insurance regulations and consumer protections, according to the CMS.